Salarius Pharmaceuticals Inc (SLRX)
2.38
-0.07
(-2.86%)
USD |
NASDAQ |
Jun 28, 16:00
2.04
-0.34
(-14.29%)
After-Hours: 20:00
Salarius Pharmaceuticals Total Assets (Quarterly): 4.884M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.884M |
| December 31, 2023 | 6.586M |
| September 30, 2023 | 8.404M |
| June 30, 2023 | 12.06M |
| March 31, 2023 | 10.06M |
| December 31, 2022 | 14.65M |
| September 30, 2022 | 19.72M |
| June 30, 2022 | 33.65M |
| March 31, 2022 | 35.51M |
| December 31, 2021 | 40.83M |
| September 30, 2021 | 44.26M |
| June 30, 2021 | 47.40M |
| March 31, 2021 | 50.77M |
| December 31, 2020 | 24.93M |
| September 30, 2020 | 23.06M |
| June 30, 2020 | 18.56M |
| March 31, 2020 | 20.07M |
| December 31, 2019 | 13.89M |
| September 30, 2019 | 14.46M |
| Date | Value |
|---|---|
| June 30, 2019 | 7.137M |
| March 31, 2019 | 8.184M |
| December 31, 2018 | 10.39M |
| September 30, 2018 | 13.94M |
| June 30, 2018 | 17.21M |
| March 31, 2018 | 26.03M |
| December 31, 2017 | 34.99M |
| September 30, 2017 | 41.21M |
| June 30, 2017 | 49.63M |
| March 31, 2017 | 55.50M |
| December 31, 2016 | 63.22M |
| September 30, 2016 | 69.95M |
| June 30, 2016 | 78.23M |
| March 31, 2016 | 87.25M |
| December 31, 2015 | 95.07M |
| September 30, 2015 | 100.76M |
| June 30, 2015 | 107.20M |
| March 31, 2015 | 111.94M |
| September 30, 2014 | 36.75M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.884M
Minimum
Mar 2024
50.77M
Maximum
Mar 2021
22.55M
Average
19.14M
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
| Theriva Biologics Inc | 48.73M |
| Oragenics Inc | 3.534M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.234M |
| Shareholders Equity (Quarterly) | 3.650M |